PATENT CLAIM ANALYSIS

Application Number: 16001153
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "134100"]

Abstract:
Methods and compositions for clonally inhibiting or clonally stimulating T-cells are provided.

Claim (Index 87):
A multimeric polypeptide according to  claim 79 , wherein:\n a) the first polypeptide comprises, in order from N-terminus to C-terminus:\n i) the peptide epitope; \n ii) the first MHC polypeptide; and \n iii) at least one immunomodulatory domain; and \n b) the second polypeptide comprises:\n i) the second MHC polypeptide.

Metadata:
- Claim Count in Document: 60.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14745170', '15040774', '12641095', '11409339', '12138867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7157887938015276
- 35 USC 102 Novelty (BERT): 0.5469983721448816
- Combined Prediction Score: 0.698909751635863
- Mean Citation Score: 343.35596600000014
- Max Citation Score: 386.52847
- Similarity Product: 290.993395427503

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test